Yahoo
TSXV - Delayed Quote CAD

NurExone Biologic Inc. (NRX.V)

0.5000 +0.0250 (+5.26%)
At close: November 6 at 3:49:26 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Assets
4,083 2,441 2,170 2,794
Total Liabilities
1,325 680 1,981 698
Total Equity
2,758 1,761 189 2,096
Balance Sheet, Supplemental
Capital Lease Obligation Maturity Schedule Total
70 31 -- --
Other Contractual Obligations Maturity Schedule Total
1,916 1,363 -- --
Total Debt
108 33 20 44
Net Debt
-2,030 -667 -521 -2,419
Working Capital
1,612 1,236 74 2,089
Invested Capital
2,866 1,794 209 2,140
Tangible Book Value
2,758 1,761 189 2,096
Common Equity Book Value
641 164 -803 759
12/31/2022 - 9/13/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: